- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The 11 worst fast food restaurants in America
- 7 things the world's happiest people do every day
- 7 grammar rules you really should pay attention to
- Why are so many parents being arrested?
- 9 things you probably didn't know about the moon
- Why America is duty bound to help Iraqi Christians
- Israel has only two choices: Eliminate the Palestinians or make peace
- The biggest lesson Obama failed to learn from Bush
- What if The Purge was real?
- What I learned from totally unplugging and shutting up for three days
Subscribe to the Week